Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 5/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL180685 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL777939 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL1148875 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL1412844 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL2221935 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL2449458 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL5442087 | 0.77 | ALDH1A1 (0.47) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL777046 | 0.76 | ALDH1A1 (0.50) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL27962643 | 0.76 | ALDH1A1 (0.53) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL19857242 | 0.76 | CA2 (0.46) | ALDH1A1CES2CES1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4000719-B1 | POLYURETHANE RESIN-FORMING COMPOSITION FOR MEMBRANE-SEALING MATERIAL, AND MEMBRANE AND MEMBRANE MODULE USING SAME | TOSOH CORP (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-12312435-B2 | Polyurethane resin-forming composition for membrane-sealing material, and membrane and membrane module using same | TOSOH CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20220275141-A1 | POLYURETHANE RESIN-FORMING COMPOSITION FOR MEMBRANE-SEALING MATERIAL, AND MEMBRANE AND MEMBRANE MODULE USING SAME | TOSOH CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| EP-4000719-A1 | POLYURETHANE RESIN-FORMING COMPOSITION FOR MEMBRANE-SEALING MATERIAL, AND MEMBRANE AND MEMBRANE MODULE USING SAME | Tosoh Corporation (JP) | 2022-05-25 | — | — | EP | disclosed |
| CN-114423798-A | Polyurethane resin-forming composition for film sealing material, and film sealing material and film assembly using same | 东曹株式会社 | 2022-04-29 | — | — | CN | disclosed |
| US-11225547-B2 | Polyurethane resin-forming composition, module membrane seal material using a hollow-shaped or flat membrane-shaped fiber separation membrane using said forming composition, and allophanate group-containing polyisocyanate composition derived from MDI and production method therefor | TOSOH CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3395849-A1 | POLYURETHANE RESIN-FORMING COMPOSITION, MODULE MEMBRANE SEAL MATERIAL USING A HOLLOW-SHAPED OR FLAT MEMBRANE-SHAPED FIBER SEPARATION MEMBRANE USING SAID FORMING COMPOSITION, AND ALLOPHANATE GROUP-CONTAINING POLYISOCYANATE COMPOSITION DERIVED FROM MDI AND PRODUCTION METHOD THEREFOR | Tosoh Corporation (JP) | 2018-10-31 | — | — | EP | disclosed |
| US-8158647-B2 | Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| US-7592133-B2 | Silver halide photographic material and image forming method using the same | FUJIFILM CORPORATION (JP) | 2009-09-22 | — | — | US | disclosed |
| EP-2056822-A1 | SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULATORS | SGX Pharmaceuticals, Inc. (US) | 2009-05-13 | — | — | EP | disclosed |
| US-7476494-B2 | Silver halide photosensitive material and image-forming method using the same | FUJIFILM CORPORATION (JP) | 2009-01-13 | — | — | US | disclosed |
| US-20090005356-A1 | SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2009-01-01 | — | — | US | disclosed |
| WO-2008150914-A1 | SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2008-12-11 | — | — | WO | disclosed |
| US-7449287-B1 | Pearlescent textured imaging supports | EASTMAN KODAK COMPANY (US) | 2008-11-11 | — | — | US | disclosed |
| US-20080268385-A1 | Silver halide photographic material and image forming method using the same | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080026333-A1 | Silver halide photosensitive material and image-forming method using the same | FUJIFILM CORPORATION | 2008-01-31 | — | — | US | disclosed |
| EP-1170629-B1 | Silver halide multilayer color photographic material | FERRANIA SPA (IT) | 2004-12-01 | — | — | EP | disclosed |
| US-20020031735-A1 | Silver halide multilaye color photographic material | FERRANIA, S.P.A., | 2002-03-14 | — | — | US | disclosed |
| EP-1170629-A2 | Silver halide multilayer color photographic material | FERRANIA S.p.A. (IT) | 2002-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005356-A1 | SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULATORS | PDXK, MAP3K4, PDPK1 | ALDH1A1 2177/4885CES2 3370/4885CES1 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.